drugset / Trial / NCT05170061

24 Hour Ambulatory Cardiac Oxygen Consumption

NCT05170061

Phase 3 Completed 26 enrolled State University of New York at Buffalo
RandomizedCrossoverTriple-blindTreatment

Summary

A randomized,double-blind, active controlled,15 week study to evaluate the effects of nebivolol and valsartan alone and in combination on 24-hour ambulatory cardiac work and variability of heart rate-mean central systolic pressure product.

Timeline

Start
2013-02
Primary completion
2014-09
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nebivolol Other / unclassified 40 mg
Comparator Valsartan Small molecule 320 mg

Indications